HealthcareServices

Global Restless Leg Syndrome Industry Insights: Key Trends and Growth Estimates

March 2, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the restless leg syndrome market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Restless Leg Syndrome Market?

The restless leg syndrome market size has experienced rapid growth in recent years. It is anticipated to expand from $2.16 billion in 2025 to $2.45 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.4%. This historical expansion can be linked to the increasing diagnosis of neurological disorders, the rising prevalence of iron deficiency conditions, greater awareness of sleep-related health issues, the proliferation of neurology specialty clinics, and enhanced access to oral medications.

The restless leg syndrome market size is anticipated to undergo substantial growth in the forthcoming years, reaching $4.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This expansion during the forecast period is attributable to an increasing emphasis on personalized neurological therapies, a rising demand for long-term symptom management solutions, the broadening of digital sleep health tools, escalating research into non-dopaminergic treatments, and improved patient awareness and diagnosis rates. Noteworthy trends predicted for this period encompass a greater utilization of dopamine modulating therapies, an increasing adoption of non-pharmacological treatment approaches, a heightened focus on sleep disorder management, the extension of personalized treatment strategies, and an enhanced understanding of secondary restless leg syndrome causes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21274&type=smp

Which Drivers Are Supporting The Rise Of The Restless Leg Syndrome Market?

The growing occurrence of iron deficiency is anticipated to fuel the expansion of the restless leg syndrome market in the future. Iron deficiency, a state where the body lacks adequate iron for healthy red blood cell production, manifests through symptoms like weariness, feebleness, and pallid skin. This rising incidence of iron deficiency stems from causes including insufficient dietary iron, blood loss, malabsorption conditions, and heightened iron needs during gestation or development. Treatment for restless leg syndrome frequently incorporates iron supplements or dietary modifications. These approaches not only ease the uncomfortable urges and sensations but also address the root iron deficiency by restoring the body’s iron reserves, boosting red blood cell formation, and re-establishing normal neurological function. As an illustration, the Nation Health Service England, an England-based government agency, reported 191,927 admissions attributed to iron deficiency during the 2023-24 period, a notable 11% rise from 2022-23, as stated in January 2025. Consequently, the escalating occurrence of iron deficiency is a significant impetus for the growth of the restless leg syndrome market.

What Leading Segments Are Studied In The Restless Leg Syndrome Market?

The restless leg syndrome market covered in this report is segmented –

1) By Type: Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome

2) By Treatment Type: Medicine And Devices, Surgery

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By Application: Neurological Treatment, Sleep Disorders, Movement Disorders, Symptom Management

Subsegments:

1) By Primary Restless Legs Syndrome: Idiopathic Restless Legs Syndrome, Hereditary Restless Legs Syndrome

2) By Secondary Restless Legs Syndrome: Iron Deficiency-related Restless Legs Syndrome, Chronic Kidney Disease-related Restless Legs Syndrome, Pregnancy-related Restless Legs Syndrome, Medication-induced Restless Legs Syndrome

Which Trends Are Influencing The Performance And Direction Of The Restless Leg Syndrome Market?

Companies operating within the restless leg syndrome (RLS) market are concentrating on developing innovative solutions, including novel non-invasive therapies, to improve symptom management and patient outcomes. These novel non-invasive therapies encompass advanced medical treatments that do not necessitate surgery or skin penetration, designed to provide relief from various conditions through sophisticated techniques such as electrical stimulation, light therapy, or external devices. As an illustration, in April 2023, Varco Leg Care, a consumer health-technology firm based in India, obtained FDA De Novo approval for its NTX100 Tonic Motor Activation (TOMAC) System. The NTX100 Tonic Motor Activation (TOMAC) System is engineered to treat moderate to severe symptoms of restless legs syndrome (RLS) and enhance sleep quality in individuals unresponsive to medications. The device functions by electrically stimulating the peroneal nerves on both sides of the body, creating tonic, sustained muscle activation that is compatible with sleep, which aids in suppressing restless leg syndrome (RLS) symptoms.

Which Major Industry Participants Are Leading The Restless Leg Syndrome Market Growth?

Major companies operating in the restless leg syndrome market are Pfizer Inc., Roche Holding AG, Merck And Co Inc., Novartis International AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., UCB S.A., Kyowa Kirin Co Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Mundipharma International Limited, Azurity Pharmaceuticals LLC, Otsuka Pharmaceutical Co Ltd., Horizon Therapeutics plc, Mylan N.V., Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Cipla Ltd., Dr Reddys Laboratories Ltd., Hikma Pharmaceuticals plc, Almirall S.A.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/restless-leg-syndrome-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Restless Leg Syndrome Market?

Europe was the largest region in the restless leg syndrome market in 2025. North-America is expected to be the fastest-growing region in the forecast period. The regions covered in the restless leg syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Restless Leg Syndrome Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21274&type=smp

Browse Through More Reports Similar to the Global Restless Leg Syndrome Market 2026, By The Business Research Company

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Narcolepsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report

Peripheral Neuropathy Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795